Bing

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Aug. 19, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it has entered into an agreement to sell its Rare Pediatric Disease Priority Review …
Financial Content · 8/19/2015
Priority Review
Sell:: CEO Martine A Rothblatt sold 18,000 shares of UTHR stock on 02/11/2010 at the average price of 59.8, the price of the stock has decreased by 4.36% since. Sell:: CEO Martine A Rothblatt sold 20,948 shares of UTHR stock on 02/08/2010 at the …
Guru Focus · 2/16/2010
Alliant Techsystems (ATK): I recommended this stock last year and since then it has doubled, said Cramer. I can't recommend it now. Getty Images United Therapeutics (UTHR): This stock has been on fire, said Cramer. I want to do a little homework before …
CNBC · ByLee Brodie · 12/3/2013
Mr. Kaplan: One of the companies I like in cardiovascular space right now is called United Therapeutics (UTHR). We initiated coverage on it several years ago, and the stock was in the single digits at that point, probably trading around $5 to $6 range.
The Wall Street Transcript · 4/5/2010
Based in Silver Spring, Maryland, this value and growth stock develops and markets therapeutic products ... Royden Ward, editor of Cabot Benjamin Graham Value Investor. United Therapeutics (UTHR) is gaining market share and has become the US leader …
The Money Show · 7/29/2014
United Therapeutics (UTHR) has zoomed to a 52-week high after a patent court ... which in recent history has mostly been used to fund operations and buy back stock. Thus, while the ruling today likely solifidies United Therapeutics’ 2015-2016 earnings ...
Barron's · 8/29/2014
United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the ... resulted principally from a 1 percent increase in our stock price during the quarter ended June 30, 2015, as compared to a 6 percent decrease in our stock ...
News-Medical · 7/28/2015
United Therapeutics stock (NASAQ: UTHR) was little changed in Tuesday trading. Its stock has gained more than 80 percent in the past 12 months.
The Business Journal · 7/28/2015
The stock market began the trading week on a cautious note with ... ARLP, WAT, POR, CIT, ICLR, WDR, UTHR, OAK, FMER, FELE, FCH, FSS, IPGP, NCI, LPT, KEM, CIR, OFC, CVLT, HSII, PCH, NTLS, SIR, CPLA, CTG, GRUB, CYNO, IPI, FBC, DHX …
Briefing Live Market Analysis · 7/27/2015
Jay A. Watson, Pharm.D. serves as an Executive Vice President of United Therapeutics Corporation and served as its Senior Vice President of Strategic Operations and Logistics.
Bloomberg · 8/28/2015